Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 326 Official Publication of Indian Association of Medical Microbiologists 
 ~   Next article
 ~   Previous article
 ~   Table of Contents

 ~   Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~   Citation Manager
 ~   Access Statistics
 ~   Reader Comments
 ~   Email Alert *
 ~   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5779    
    Printed251    
    Emailed5    
    PDF Downloaded363    
    Comments [Add]    
    Cited by others 8    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2012  |  Volume : 30  |  Issue : 4  |  Page : 448-452

Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?


1 Department of Infectious diseases and Clinical Microbiology, Ministry of Health Okmeydani Training and Research Hospital, Istanbul, S.B. Okmeydani Egitim ve Arastirma Hastanesi Sisli-Istanbul, Turkey
2 Department of Anaesthesiology and Reanimation, Ministry of Health Okmeydani Training and Research Hospital, Istanbul, S.B. Okmeydani Egitim ve Arastirma Hastanesi Sisli-Istanbul, Turkey

Correspondence Address:
H Gedik
Department of Infectious diseases and Clinical Microbiology, Ministry of Health Okmeydani Training and Research Hospital, Istanbul, S.B. Okmeydani Egitim ve Arastirma Hastanesi Sisli-Istanbul
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0255-0857.103767

Rights and Permissions

Purpose: To evaluate the outcomes of the patients who were infected with colistin-only-susceptible (COS) Acinetobacter baumannii and treated with either colistin monotherapy or colistin combined therapy. Materials and Methods: This retrospective case-control study was conducted in the training and research hospital with an 800 beds between August 2008 and December 2011. The patients, who were infected with COS A. baumannii and received either colistin monotherapy or colistin combined therapy, were included into the study. Results: In total, 51 patients fulfilling study criteria were evaluated. Colistin monotherapy was found effective as much as colistin combined therapy in terms of clinical and microbiological responses in patients with ventilator associated pneumonia (VAP) and also in patients with blood stream infections. Conclusion: Although there is no randomised controlled study yet, colistin monotherapy and colistin combined therapy are likely to achieve similar treatment responses rates. Heteroresistant strains can emerge in patients who receive colistin monotherapy






[FULL TEXT] [PDF]*


        
Print this article     Email this article

© 2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04